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BMP4 and Madh5 regulate the erythroid response to acute anemia
Laurie E. Lenox, John M. Perry, and Robert F. Paulson
Acute anemia initiates a systemic response
that results in the rapid mobilization and
differentiation of erythroid progenitors in
the adult spleen. The ﬂexed-tail (f) mutant
mice exhibit normal steady-state erythro-
poiesis but are unable to rapidly respond
to acute erythropoietic stress. Here, we
show that f/f mutant mice have a mutation
in Madh5. Our analysis shows that BMP4/
Madh5-dependent signaling, regulated by
hypoxia, initiates the differentiation and
expansion of erythroid progenitors in the
spleen. These ﬁndings suggest a new
model where stress erythroid progeni-
tors, resident in the spleen, are poised to
respond to changes in the microenviron-
ment induced by acute anemia. (Blood.
2005;105:2741-2748)
© 2005 by TheAmerican Society of Hematology
Introduction
Erythropoiesis in the bone marrow is primarily homeostatic;
however, the situation is dramatically different in the adult spleen
in response to acute erythropoietic stress, where rapid, expansive
erythropoiesis occurs. Previous work suggested a model where
acute anemia leads to tissue hypoxia, which induces expression of
erythropoietin (Epo) in the kidney. Increased levels of serum Epo
mobilize cells from the bone marrow, which migrate to the spleen
where they expand and differentiate.1,2 The spleen contains a
unique microenvironment that can support expansive erythropoi-
esis.3 However, the signals that regulate the increase in splenic
erythropoiesis in response to acute anemia are not clear.
The expansive erythropoiesis observed in the adult spleen is
similar to fetal liver erythropoiesis during development.4 In both
cases rapid erythroid development occurs. Similar to the spleen,
fetal liver stromal cells are capable of supporting the expansion of
erythroid progenitors.5 Because of these common features, it has
been suggested that splenic and fetal liver erythropoiesis may be
mechanistically similar.This link between the fetal liver and spleen
is apparent in mice with a mutation at the ﬂexed-tail (f) locus.
During fetal development, f/f mutant embryos exhibit a severe
microcytic, hypochromic anemia.6-8 The f/f fetal livers contain
about 50% the normal number of erythroid progenitors9,10 and have
a maturation defect, which results in the production of large
numbers of siderocytes or erythrocytes that contain nonheme iron
granules.8,11 Despite these defects, the anemia of f/f mice resolves
about 2 weeks after birth.Adult f/f mice exhibit normal numbers of
steady-state erythroid progenitors.12 However, they are unable to
respond rapidly to acute erythropoietic stress. This defect is
manifested by a delay in the expansion of erythroid progenitors in
the spleen and a delay in the appearance of reticulocytes following
phenylhydrazine (PHZ)–induced acute anemia.13 Despite the de-
layed response, adult f/f mice do not exhibit the maturation defect
present during fetal liver erythropoiesis because no siderocytes are
observed during the recovery from acute anemia.14 These observa-
tions demonstrate that the f gene product plays a key role in
regulating the expansion and maturation of erythroid progenitors at
times of great erythropoietic need.
Previous work has suggested that f/f mice have a mutation in
sideroﬂexin 1 (sfxn1), a putative mitochondrial transporter, which
is proposed to play a role in the transport of molecules required for
heme biosynthesis.15 In this report, however, we show that f/f mice
have a mutation in the Madh5 gene, which directly affects the
ability of f/f mice to respond to acute anemia. Madh5 functions as a
receptor-activated Smad downstream of the bone morphogenetic
protein 2 (BMP2), 4, and 7 receptors.16,17 Previous work has
implicated BMPs and in particular BMP4 in the development of
mesodermal cells that will give rise to hematopoietic cells early in
development.18 Our work shows that in response to acute anemia,
BMP4 is rapidly induced in the spleen. BMP4 acts on an immature
progenitor cell causing it to differentiate into an Epo-responsive
stress erythroid progenitor. Cell-sorting experiments showed that
BMP4-responsive cells exhibit the same cell surface phenotype as
the bone marrow-derived megakaryocyte-erythroid progenitors
(MEPs)19; however, only spleen MEPs respond to BMP4. These
results demonstrate that these spleen progenitors exhibit properties
that are distinct from bone marrow erythroid progenitors, suggest-
ing that they represent a population of “stress erythroid progeni-
tors” resident in the spleen whose function is to rapidly generate
erythrocytes at times of great erythropoietic need.
Materials and methods
Mice
C57BL/6 and C57BL/6-f mice were obtained from the Jackson Laboratory
(Bar Harbor, ME). Madh5/ mice were obtained from Dr C. Deng
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and Kidney Diseases, Bethesda, MD).20All mice were approximately 6 to 8
weeks old, and controls were matched for age. Acute anemia was induced
by injection of PHZ (Sigma, St Louis, MO) at a concentration of 100 mg/kg
mouse in phosphate-buffered saline (PBS).
Colony assays for BFU-Es
Splenocytes, bone marrow, and peripheral blood cells were isolated from
C57BL/6 control, f/, and f/f mice. Then, 1  105/mL nucleated bone
marrow and peripheral blood cells and 2  106/mL nucleated splenocytes
were plated in methylcellulose media (StemCell Technologies, Vancouver,
BC, Canada) containing 3 U/mL Epo with or without either 10 ng/mL
interleukin 3 (IL-3; Sigma) or 0.15 to 15 ng/mL BMP4 (R&D Systems,
Minneapolis, MN) where indicated. Erythroid burst-forming units (BFU-
Es) were scored as described.21 For the BMP4 preincubation experiment,
splenocytes and bone marrow cells from C57BL/6 and f/f mice were
incubated for 24 hours in Iscove modiﬁed Dulbecco medium (IMDM) plus
5% fetal calf serum (FCS) with or without 15 ng/mL BMP4. Colony assays
were then performed as indicated with or without 15 ng/mLBMP4 for each.
Characterization of the Epo sensitivity of the stress BFU-Es
Colony assays were performed as described (see “Colony assays for
BFU-Es”) on bone marrow and spleen cells in the presence of 0.1, 0.3, 1,
3, and 10 U/mL Epo as indicated. Additionally, bone marrow cells
were supplemented with 50 ng/mL stem cell factor (SCF), whereas
splenocytes were supplemented with 15 ng/mL BMP4. Colonies were
scored as described.21
Cloning of Madh5 mRNAs from f/f, f/, and control mice
Total RNA was isolated from single-cell suspensions of spleen cells using
the TriZol reagent (Invitrogen, Carlsbad, CA) according to the manufactur-
er’s instructions. cDNA was generated and Madh5 cDNA was ampliﬁed
using 5-GGGGCCGAGCTGCTAAT-3 and 5-CTATGAAACAGAA-
GAAATGGGG-3 primers.
Analysis of BMP4 expression
Total RNA isolated from bone marrow or spleen cells homogenized in
TriZol (Invitrogen) was reverse transcribed into cDNA. Polymerase chain
reaction (PCR) was performed using primers 5-TGTGAGGAGTTTCCAT-
CACG-3 and 5-TTATTCTTCTTCCTGGACCG-3.
Staining of spleen sections with anti-BMP4 antibodies
Spleens were harvested on the indicated days after PHZ-induced anemia
and ﬁxed in zinc ﬁxative, and parafﬁn-embedded tissue sections were cut.
The expression of BMP4 was analyzed as described22 using anti-BMP4
antibody (Novocastra Laboratories/Vector Laboratories, Burlingame, CA).
Slides were analyzed by confocal microscopy.
Cell staining and sorting
Bone marrow and spleen MEPs were sorted as previously described19 with
the exception that ﬂuorescein isothiocyanate (FITC)–conjugated anti-c-kit
was used (and allophycocyanin [APC]–conjugated anti-c-kit and FITC-
conjugated anti-CD34 eliminated) for spleen sorts after determining that
FITC-conjugated anti-CD34 did not stain spleen cells. Cells were washed
twice and sorted using a Coulter Elite ESP ﬂow cytometer (Coulter
Electronics, Hialeah, FL). Cells were plated in methylcellulose and scored
as described (see “Colony assays for BFU-Es”).
Analysis of BMP4 signaling in W-20-17 osteoblast cells
The cDNAs coding the f/f truncated transcripts, as well as full length
Madh5, were cloned into the MSCVneo retroviral construct. Recombinant
virus was generated as previously described23 and used to infect W-20-17
cells(AmericanTypeCultureCollection,Manassas,VA).Poolsofneomycin-
responsive (neoR) colonies were plated and induction of alkaline phospha-
tase by BMP4 was measured as described.24
Results
The ﬂexed-tail mutant mice exhibit a delayed expansion of
erythroid progenitors in the spleen in response to acute anemia.13
To identify the origin of the defect, we characterized the response
of f/f, f/, and control mice to acute anemia using a modiﬁed
PHZ-induced hemolytic anemia protocol that rapidly induced
severe anemia (hematocrit 30% treated versus 50% untreated) in 12
hours. Similar to previous ﬁndings, we observed that early
erythroid progenitors (BFU-Es) in the bone marrow were not
elevated in response to anemia and in fact gradually declined over
time (Figure 1A). The greatest difference was observed in the
spleen and peripheral blood. In the spleen, control mice exhibited
an expansion of BFU-Es that peaked at 36 hours after anemia
induction. Similarly, f/ mice showed the greatest expansion at 36
hours but unlike control mice we also observed a signiﬁcant
expansion later at 4 and 6 days after anemia. In contrast, the
expansion was signiﬁcantly delayed in the f/f mice where it peaked
at 4 days after anemia induction (Figure 1B). These results
correlate with previous data showing that the f/f mice were delayed
in the expansion of erythroblasts in the spleen following anemia
induction.13 In the peripheral blood, however, we did not identify
any BFU-Es potentially migrating from the bone marrow to the
spleen at any of the time points in the f/f, f/ or control mice (data
not shown). These results suggest a new model where progenitor
cells resident in the spleen mediate the response to acute anemia.
Splenic erythroid progenitors that expand in response to acute
anemia exhibit distinct properties
Bone marrow BFU-E colonies have a distinct morphology, develop
in 7 days in culture, and require 2 signals to develop. The ﬁrst
signal is Epo and the second is a burst-promoting activity (BPA),
which in vivo is SCF, but in vitro IL-3 or granulocyte-macrophage
colony-stimulating factor (GM-CSF) can substitute. We observed
that the BFU-E colonies from spleen 36 hours after anemia
induction exhibited altered morphology. The colonies were larger
and had more small satellite colonies associated with the BFU-Es.
They also grew faster, such that spleen colonies grown for 5 days
resembled bone marrow colonies that had grown for 7 days, and
spleen BFU-Es were routinely grown for 5 days out of conve-
nience. In many ways these erythroid progenitors resembled fetal
liver erythroid progenitors, which are known to exhibit a faster cell
cycle than bone marrow BFU-Es. Fetal liver BFU-Es can also
develop in media containing only Epo, without an added BPA.25
Given that f/f mice also have a defect in fetal liver, we repeated the
analysis of bone marrow, peripheral blood, and spleen BFU-Es
following induction of acute hemolytic anemia; however, this time
cells were cultured in media containing only Epo. The bone
marrow contained very few cells that could form BFU-E colonies
in Epo-only media (Figure 1C). In the control and f/ spleens,
however, the expansion of BFU-Es at 36 hours was completely
recapitulated when the cells were plated in Epo-only media (Figure
1D). If fact, more splenic BFU-E colonies developed in this media.
Similar to the initial observations, the f/f mice exhibited a delay in
the expansion of BFU-Es with the maximum number of colonies
observed at 4 days after anemia induction. The number of spleen
BFU-Es observed under the Epo-only culture conditions responded
in a linear manner when increasing numbers of cells were plated,
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not shown). Once again we did not identify any BFU-Es in the
peripheral blood at any of the time points in the f/f, f/, or control
mice indicating that these BFU-Es are resident in the spleen.
In addition to shorter cell cycling times, fetal liver erythroid
progenitors also exhibit an increased sensitivity to Epo.25 We
tested the Epo sensitivity of splenic erythroid progenitors. We
observed that these progenitor cells were actually less sensitive
to Epo than bone marrow cells (Figure 1E). Decreased Epo
sensitivity is an ideal property of a stress progenitor because
differentiation of these progenitors would be dependent on the
high serum Epo concentrations only present during the response
to acute anemia. Taken together, these results suggest that the
spleen contains a distinct population of erythroid progenitors
that are poised to respond to acute erythroid stress. These
progenitors, which we will refer to as “stress BFU-Es,” form
large burst colonies in 5 days, require only Epo at relatively high
levels to develop, and are resident in the spleen.
f/f mice have a mutation in the Madh5 gene
The ﬂexed-tail locus is located on mouse chromosome 13.26 We
generated a panel of 408 F2 progeny using a F1(C57BL/6-f/f X
BALB/c) intercross. F2 progeny were scored at birth for anemia by
hematocrit and for the presence of siderocytes by staining blood
smears for iron deposits. We constructed a high-resolution genetic
linkage map of the f locus and initially localized the gene 0.6 cM
distal to the microsatellite marker D13MIT13. Further analysis of
markers showed that the f locus cosegregated with the marker
D13Mit208 (Figure 2A). Our linkage mapping results differ from
the recent work from Fleming et al.15 They mapped the f locus to a
more proximal position on chromosome 13 and identiﬁed a
mutation in the sideroﬂexin 1 (sfxn1) gene, which they proposed
caused the f/f mutant phenotype. Because there is only a single
allele of the f mutation, all f/f mice must carry the same mutation.27
Like Fleming et al,15 our colony of C57BL/6J-f mice was derived
from C57BL/6J-f mice obtained from the Jackson Laboratory.
However, when we scored our f/f progeny for the presence of the
mutation in exon 2 of Sfxn1, we identiﬁed f/f progeny that exhibited
severe anemia and siderocytes at birth, but were heterozygous for
the insertion mutation (Supplementary Figure 1; see the Supplemental
Figures link on the Blood website at the top of the online article).
These results suggest that in our colony, the f mutation has been
separated from the mutation in Sfxn1 by recombination and, thus,
mutation of Sfxn1 cannot be the cause of the f/f mutant phenotype.
To identify candidate genes for the f locus, we initially took
advantage of the fact that one of our ﬂanking markers, D13Mit13,
is located in the IL-9 gene.28 This region of mouse chromosome 13
is homologous to human chromosome 5q31. Comparison of the
human and mouse gene maps in the region immediately surround-
ing IL9 revealed MADH5 was located in this region.The possibility
that Madh5 was encoded by the f locus was supported by the recent
mouse genome sequence release that showed that D13MIT208 is
located in the Madh5 gene. Previous work in Xenopus and mice has
demonstrated that BMP4/Madh5-dependent signals play a key role
in the development of erythroid cells.18,29 Madh5 is highly ex-
pressed in the fetal liver during development,30 and we have
observed Madh5 expression in the spleen of mice recovering from
PHZ-induced acute anemia (data not shown).
Figure 1. Analysis of BFU-E expansion during the
recovery from PHZ-induced acute hemolytic anemia.
(A) Bone marrow and (B) spleen BFU-Es from C57BL/6-
f/f (f), C57BL/6-f/ (u), and C57BL/6-/ control mice
() during the recovery from PHZ-induced acute anemia.
Cells were plated in methylcellulose media containing
Epo (3 U/mL) and IL-3 (10 ng/mL). (C) Bone marrow and
(D) spleen BFU-Es from C57BL/6-f/f, C57BL/6-f/, and
C57BL/6-/ control mice during the recovery from
PHZ-induced acute anemia. Cells were plated in methyl-
cellulose media containing only Epo (3 U/mL). (E) Sensi-
tivity of bone marrow and spleen BFU-Es to Epo. A total
of 5  105 bone marrow or spleen cells were plated in
methylcellulose media containing the indicated concen-
trations of Epo plus 50 ng/mL SCF (bone marrow, f)o r
15 ng/mL BMP4 (spleen, ). The asterisk indicates
P  .02. Error bars represent standard deviation.
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the entire coding region of Madh5 by reverse transcription-PCR
(RT-PCR)fromspleenRNAisolatedfromC57BL/6J-/,C57BL/
6J-f/, and C57BL/6J-f/f mice. Only the expected product was
observed in wild-type mice; however, in both f/ and f/f mice an
additional band was observed (Figure 2B). The majority of the
mRNA in f/ mice is the wild-type fragment, whereas in f/f mice
the majority of the mRNA is a truncated mRNA. The level of
wild-type message in f/f mutant mice varies, but most express less
than 30% wild-type mRNA. Analysis of the sequence of the
truncated mRNA showed that it is a mixture of 2 mis-spliced
mRNAs. The consistent feature of these mutant mRNAs was the
deletion of exon 2, which contains theAUG initiator codon. In one
of the mis-spliced mRNAs we also observed deletion of exon 4 and
insertion of a 12-nucleotide sequence at the splice junction between
exons 6 and 7. In the other mis-spliced mRNA, we observed an
aberrant splice into the middle of exon 3 (Figure 3). There were no
other alterations in the coding sequence of Madh5 observed in f/f
mice. Southern blot analysis of the Madh5 genomic region did not
identify any deletions or rearrangements in the Madh5 locus
suggesting that the alterations in the Madh5 mRNA in f/f mice are
due to defects in mRNA splicing (data not shown). We have
sequenced the entire Madh5 transcription unit from f/f and control
mice and have not identiﬁed a consistent mutation, which suggests
that the defect may lie in the promoter or 3 to the Madh5gene. We
are currently investigating this possibility.
BMP4 expression is induced in the spleen just prior to the
expansion of “stress BFU-Es”
The identiﬁcation of aberrantly spliced Madh5 mRNA in f/f mice
suggests a role for the BMP2, 4, and 7 signaling pathways in the
Figure 2. Genetic linkage map of the f locus and molecular analysis of Madh5
transcripts in f/f, f/, and control mice. (A) Linkage map of the f locus on mouse
chromosome 13. The position of the markers on chromosome 13 according to NCBI m33
mouse genome assembly is indicated. The number of recombinants in each interval
amongthescoredintercrossF2progenyisindictedattheright.ThepositionsofMadh5and
Sfxn1 are shown. (B) The coding region of the Madh5 was cloned by RT-PCR of spleen
RNAfrom the indicated mice. The arrows indicate the position of the wild-type and mutant
mRNAs. The asterisk indicates a nonspeciﬁc background band. The exon structure of the
wild-typeandf/fmRNAsisindicatedattheright.Thef/fmouseshownhereisanexampleof
a mutant mouse that expresses very little wild-type Madh5 mRNA.
Figure 3. Analysis of BMP4 expression during the recovery from acute anemia. (A) RT-PCR analysis of BMP4 expression in C57BL/6-/ control (left) and C57BL/6-f/f
(right) mice.Arrows indicate the positions of the BMP4-speciﬁc band and the hypoxanthine guanine phosphoribosyl transferase 1 (HPRT) control band and the number of PCR
cycles is indicated at the right. (B) Spleen sections from C57BL/6-/ (top row) and C57BL/6-f/f (bottom row) mice stained with anti-BMP4 antibodies at the indicated times
following PHZ-induced acute anemia. BMP4 staining was visualized using an Olympus FV300 confocal laser scanning microscope equipped with a UPLANFL 100/0.3
objective lens (Olympus, Melville, NY). Images were acquired using Fluoview version 4.3 software (Olympus). (C) RT-PCR analysis of BMP4 expression in MSS31 spleen
stromal cells grown at normoxic (20%) and hypoxic (6%) conditions (top). The position of the putative hypoxia-inducible element in the BMP4 gene is indicated and an
alignment of this sequence from mouse, human, and rat is presented (bottom).
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BMP2, 4 and 7 in the spleen during the response to acute anemia by
RT-PCR. BMP2 is not expressed in the spleen at any time point
during the recovery from acute anemia, whereas BMP7 is ex-
pressed at low levels at all times tested (data not shown). BMP4 is
not expressed in the spleen of untreated mice; however, expression
is initiated at 12 hours and peaks at 24 hours with lower levels at 36
and48hoursafteranemiainduction.Wealsoobservedlowlevelsat
6 and 8 days after anemia induction. The highest expression
observed at 24 hours after anemia induction is just prior to the
expansion of “stress BFU-Es” in the spleen (Figure 3A). Staining
of spleen sections with anti-BMP4 antibodies showed that BMP4
protein was not present in untreated mice; however, high levels of
BMP4 were observed throughout the red pulp of the spleen at 24
and 36 hours after anemia induction, but expression is severely
decreased by 48 hours and essentially off by 96 hours after anemia
induction (Figure 3B). BMP4 was excluded from the white pulp.
The expression of BMP4 is tightly regulated during the
response to acute anemia. During the analysis of the BMP4
expression by RT-PCR, we also tested the expression in f/f mice.
Surprisingly, BMP4 expression is expanded in the mutant mice.
Untreated mice and all the time points during the response to acute
anemia exhibit BMP4 expression (Figure 3A). The expression of
BMP4 in untreated f/f correlates with the observation of stress
BFU-Es in these mice (Figure 1D). Despite the constitutive mRNA
expression, BMP4 protein expression was not observed at all
time points, suggesting that BMP4 expression is regulated post-
transcriptionally. These observed differences in BMP4 expression
in f/f mice suggest that the regulation of BMP4 may require a
Madh5-dependent signal to inhibit the expression of BMP4 in the
spleens of untreated mice.
The increase in serum Epo concentration that occurs during the
response to acute anemia is regulated at the transcriptional level by
the hypoxia-inducible transcription factor complex, HIF-1.32 Given
that Epo expression is regulated by hypoxia we tested whether
BMP4 expression is also induced by hypoxia. MSS31 spleen
stromal cells,33 which support erythroid progenitor cell expansion
in vitro, were grown at normoxic (20% O2) and hypoxic (6% O2)
conditions. At low oxygen concentration, the expression of BMP4
was signiﬁcantly increased (Figure 3C). Analysis of the BMP4
gene revealed the presence of a putative HIF element in the
3-untranslated region (UTR), which is conserved in the human,
rat, and mouse BMP4 genes.
BMP4 causes the differentiation of an immature progenitor cell
into an Epo-responsive stress BFU-E
Given that BMP4 was induced in the spleen just prior to the
expansion of stress BFU-Es, we next tested whether culturing
spleen cells from untreated mice in Epo and BMP4 could induce
the expansion of stress BFU-Es. Spleen cells from untreated f/f and
control mice were plated in methylcellulose media containing
3 U/mL Epo and various concentrations of BMP4. Control spleen
cells responded in a dose-dependent manner to BMP4 with a
6.1-fold increase in the number of stress BFU-Es seen at a
15-ng/mL BMP4 dose (Figure 4A). The f/f spleen cells failed to
respond to BMP4 except at the highest concentration, which is
consistent with their defect in Madh5. BMP4 had very little effect
on the number of BFU-Es in the bone marrow, suggesting that there
are very few BMP4-responsive erythroid progenitor cells in the
bone marrow (Figure 4A). We did not detect any BMP4-responsive
cells in the peripheral blood in untreated or in mice treated with
PHZ to induce anemia (data not shown).
BMP4 can induce the expansion of stress BFU-Es, but the
mechanism by which BMP4 affects these cells is not clear. One
might imagine 2 possible roles for BMP4. First, BMP4 could
synergize with Epo to promote the differentiation of stress BFU-Es,
much like SCF synergizes with Epo to increase the number and size
of bone marrow BFU-Es.34 Alternatively, BMP4 may act on an
earlier cell inducing it to differentiate into an Epo-responsive stress
BFU-Es. This possibility is similar to the situation in Xenopus
embryos where BMP4 can induce mesodermal cells to become
erythroid progenitors.18 To test these possibilities, we preincubated
spleen cells from untreated mice with and without BMP4 for 24
hours, washed the cells, and then plated them in methylcellulose
media containing either Epo alone or Epo and BMP4. The cells
preincubated with BMP4 and plated in Epo alone gave rise to as
many stress BFU-E colonies as the cells plated in Epo and BMP4
(Figure 4B). These results suggest that a short exposure to BMP4
promotes the differentiation of an immature BMP4-responsive
(BMP4R) cell into an Epo-responsive stress BFU-E.
f is a gain-of-function allele of Madh5
Our analysis shows that the f mutation maps to the Madh5 locus, f/f
mice express mis-spliced mRNAs, and spleen cells from f/f fail to
respond to BMP4. Although all of these data are consistent with f
being a mutation in Madh5, we crossed f mice with Madh5/
mice20 to generate f/Madh5 mice to test whether f was allelic to
Madh5. Figure 5A shows the expansion of stress BFU-Es in
f/Madh5 and /Madh5 during the recovery from acute anemia.
Both genotypes exhibit an altered recovery when compared to
control (compare Figure 5A with Figure 1D). The peak expansion
of stress BFU-Es in f/Madh5 mice is delayed until 48 hours,
whereas /Madh5 mice exhibit an increase in stress BFU-Es at
36 hours, and they continue to expand at 48 hours. Analysis of
BMP4 mRNAexpression in these mice showed that both f/Madh5
and /Madh5 expressed BMP4 at all time points during the
recovery (Figure 5B). These data are similar to what is observed in
f/f and f/ mice, suggesting that a Madh5-dependent signal is
required for the regulation of BMP4 in the spleen. These results
show that the phenotype of f/Madh5 is more severe than f/ and
/Madh5, which demonstrates that f is allelic to a targeted
mutation in Madh5. Classical genetic analysis, however, would
Figure 4. Analysis of the ability of BMP4 to induce the formation of stress
BFU-Es in spleen cells from untreated mice. (A) Bone marrow (top) and spleen
(bottom) cells from untreated f/f (f) and control mice (u) were plated in methylcellu-
lose media containing Epo (3 U/mL) and the indicated concentration of BMP4.
(B) Spleen cells from C57BL/6-/ mice were preincubated without (f) or with
BMP4 (15 ng/mL; u) for 24 hours, washed, and then plated in the methylcellulose
media containing either Epo (3 U/mL) alone or Epo plus BMP4 (15 ng/mL). Error bars
indicate standard deviation.
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Madh5 then f/Madh5 should have a more severe phenotype than
f/f. We observed the opposite that the f/f phenotype was the most
severe. These data suggest that the f mutation in Madh5 is a
neomorphic or gain-of-function mutation in Madh5. To test this
possibility, we expressed each of the 2 mis-spliced Madh5 mRNAs
identiﬁed in f/f mice in a cell line that responds to BMP4 and
analyzed whether these mRNAs could affect BMP4-dependent
responses. W-20-17 is a mouse osteoblast cell line that differenti-
ates in response to BMP4.24 The mutant transcripts as well as
controls were cloned into the MSCV-neo retroviral vector and
W-20-17 cells were infected with recombinant retroviruses. Al-
though the mis-spliced messages lack the initiator ATG of wild-
type Madh5, both messages contain in-frame ATGs that could be
used to initiate the translation of truncated forms of the Madh5
protein (Figure 6A). Treatment of W-20-17 cells with BMP4
induces the osteoblast differentiation program as measured by an
increase in alkaline phosphatase (AP) activity. W-20-17 cells that
express either f mutant message have a profound defect in
BMP4-dependent induction ofAPactivity with mutant message no.
1 exhibiting the most severe defect (Figure 6B).These results show
that the mis-spliced Madh5 mRNAs present in f/f mice dominantly
suppress BMP4-dependent signals. Furthermore, W-20-17 cells do
not express endogenous Madh5 (data not shown), but rather rely on
Madh1 and Madh8 to transmit BMP4 signals, which suggests that
the mis-spliced mRNAs also inhibit signaling through Madh1 and
Madh8. These results explain why f/Madh5 mice have a less
severe phenotype than f/f because the f/Madh5 mice express lower
levels of the mis-spliced mRNAs.
Spleen MEPs are the BMP4R cells
To further characterize the BMP4R cell, we fractionated spleen
cells and assayed for response to BMP4. Initially we sorted cells
based on their expression of lineage-restricted markers. BMP4R
cells were observed in the Lin population (Figure 7A). Previous
work had demonstrated that mice with a mutation in the Kit
receptor, Dominant white spotting (W) mice, failed to respond
rapidly to acute anemia, which suggested that the BMP4R cell may
also be Kit.35 Analysis of LinKit spleen cells conﬁrmed this
hypothesis because BMP4R cells were not detected in LinKit
spleen cells (Figure 7B). In the bone marrow, erythroid progenitors
are derived from the common myeloid progenitors (CMPs) and the
MEPs.19 CMPs and MEPs are Kit, but differ in their expression of
CD34. We analyzed the expression of CD34 in LinKit spleen
cells and observed that they were CD34, suggesting that the
spleen does not contain CMPs (data not shown). Isolation of MEPs
from spleen showed that they responded to BMP4 (Figure 7C).
Interestingly, MEPs isolated from bone marrow failed to respond to
BMP4. These results suggest that the unique microenvironment of
the spleen alters the properties of MEPs, rendering them responsive
to BMP4, and further underscores our assertion that distinct
erythroid progenitors are present in the spleen poised to respond to
acute erythroid stress.
Discussion
Acute anemia induces a robust erythroid response that occurs in the
spleen. Our data demonstrate that in response to PHZ-induced
anemia, dedicated stress progenitors resident in the spleen respond
to a BMP4-dependent signal, which leads to the rapid expansion of
erythroid progenitors. These data differ from the previous model
that suggested that high serum Epo levels induced by tissue
hypoxia mobilized erythroid progenitors from the bone marrow to
spleen where they expanded and differentiated.1,2 This early model
was based on the observation that BFU-Es were present in the
peripheral blood during the recovery from acute anemia.1 However,
we did not observe migration of erythroid progenitors in our studies
and all of our data suggest that stress BFU-Es are resident in the
spleen. One reason for the differences in our data could be that
earlier experiments cultured BFU-Es for 10 days rather than the 5
to 7 days used in our studies. The longer culture conditions may
have allowed more immature cells to develop. In addition, we used
a modiﬁed protocol to induce anemia, which used a single injection
of a high dose of PHZ. This protocol results in a synchronous and
reproducibleexpansionoferythroidprogenitors.Theearlierexperi-
ments used multiple injections of a low dose of PHZ. We have
found that multiple low doses of PHZ did not allow us to look at
early events during the recovery and did not produce reliable
results (L.E.L. and R.F.P., unpublished observations, 1999).
The earlier model suggested that bone marrow progenitors
develop in the spleen during the recovery. Our data, however,
demonstrate that specialized BMP4R cells are resident in the
spleen. BMP4 induces these cells to differentiate, leading to the
expansion of stress BFU-Es in the spleen but not in the bone
Figure 6. Analysis of the effect of overexpression of the f mis-spliced Madh5
mRNAs on BMP4 signaling in W-20-17 osteoblast cells. (A) Schematic represen-
tation of the f mis-spliced Madh5 mRNAs and control Madh5 mRNA. The position of
the endogenous ATG is indicated in the wild-type mRNA. The asterisks indicate the
positions of putative in-frame ATGs in the mis-spliced mRNAs. The arrowhead
indicates the 12-nucleotide insertion between exons 6 and 7. (B) Induction of alkaline
phosphatase activity by BMP4 in control W-20-17 cells and W-20-17 cells expressing
wild-type or mis-splice Madh5 mRNAs.Alkaline phosphatase activity was normalized
to protein concentration and expressed in relative units. Error bars represent SEM.
Figure 5. Analysis of the recovery from acute anemia in f/Madh5 and
/Madh5 mice. (A) Analysis of the expansion of stress BFU-Es in the spleen of
C57BL/6-f/Madh5 () and C57BL/6-/Madh5 mice (f). Spleen cells were plated
in methylcellulose media containing 3 U/mL Epo. (B) Expression of BMP4 in the
spleen of C57BL/6-f/Madh5 and C57BL/6-/Madh5 mice. The BMP4 and HPRT
control bands are indicated by the arrows. These results are from 25 cycles of PCR.
Error bars represent SEM.
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bone marrow BFU-Es in that they form large burst colonies in 5
days rather than 7 days and they require only Epo without any
added BPA for BFU-E formation. Fractionation of spleen cells
revealed that BMP4R cells are contained within the MEP popula-
tion. However, only spleen MEPs are able to respond to BMP4.
This observation suggests that the spleen microenvironment may
provide a specialized signal that enables spleen MEPs to respond to
BMP4.3 This situation would be similar to chondrogenesis, where
presomitic mesoderm cells require BMP signals to differentiate
into chondrocytes but are unable to respond to BMP unless they
ﬁrst encounter a sonic hedgehog signal.36
The notion that f/f mice have a defect in a spleen progenitor was ﬁrst
suggested almost 30 years ago. Gregory et al showed that f/f mice had
normal numbers of BFU-Es and erythroid colony-forming units (CFU-
Es), but were defective in transient endogenous colony-forming units
(TE-CFUs).12 This population of cells was deﬁned by an in vivo assay
that identiﬁes progenitor cells that form endogenous spleen colonies
following sublethal irradiation and stimulation of erythropoiesis by Epo
injection or bleeding.37 BMP4R cells exhibit many of the properties
expected in a putative TE-CFU. They are resident in the spleen, rapidly
expand at times of great erythropoietic need, and require high levels of
Epo for differentiation. In addition to TE-CFUs, previous work has
identiﬁed other stress erythroid progenitors in the spleen. Mice with
mutations in the glucocorticoid receptor are slow to respond to acute
anemia and it has been suggested that a CD34KitTER119 popula-
tion of cells fails to expand in these mutant mice.38 Another group
identiﬁeda4A5TER119bipotentialmegakaryocyte-erythroidprogeni-
tor (MEP) that expands in the spleen following PHZ-induced anemia.39
However, both of these progenitors express the lineage-restricted
marker, TER119, which is not present on BMP4R cells or BFU-Es in
general.40 The relationship between these progenitors and the BMP4R
cells and the stress BFU-Es is not understood, but the most likely
possibility is that they are derived from BMP4Rcells.
Our analysis of f/f mice has identiﬁed a mutation in Madh5,
which causes aberrant splicing. The mis-spliced Madh5 mRNAs
exert a dominant-negative effect on BMP4 signaling, which
suggests that f represents a gain-of-function allele of Madh5. These
mis-spliced mRNAs inhibit BMP4-dependent signals in W-20-17
osteoblast cells, which do not express endogenous Madh5, suggest-
ing that the f mutant mRNAs inhibit BMP4 signaling mediated by
Madh1 and or Madh8. This possibility is consistent with our
observationthatf/fexhibitsamoreseverephenotypethanf/Madh5
mice. In this case, f/f mice express higher levels of mis-spliced
mRNAs and thus would have a more signiﬁcant impairment of
BMP4-dependent signaling than f/Madh5 mice.
Previous work from Fleming et al suggested that f was a
mutation in the putative mitochondrial transporter Sfxn1.15 We
show that the mutation in Sfxn1has been separated from the f locus
by recombination in f/f mice in our colony. All of our observations
characterizing the BMP4-dependent expansion of stress BFU-Es in
the spleen during the recovery from acute anemia and the defective
response in f/f mice support the idea that the f locus encodes
Madh5. In addition, other phenotypes associated with f/f mice, tail
ﬂexures, and white belly spots, can easily be explained by defects
in the BMP4 signaling pathway. The tail ﬂexures are caused by
defects in chondrogenesis that result in vertebrae fusion.41 BMP4
plays a key role in regulating chondrocyte development.36 Further-
more, white belly spots are caused by defects in the migration of
neural crest-derived melanocytes.42 Inhibition of BMP4 signaling
in chick embryos impairs the ability of neural crest cells to
migrate.43 Thus, the combination of the observed defects in
BMP4-dependent signals in f/f mice with the genetic interactions of
f and Madh5 alleles demonstrates that the f locus encodes Madh5.
Acknowledgments
We thank M. Yon, A. Lariviere, and P. Porayette for technical
assistance and for discussion of the manuscript; C. Deng for the
Madh5/ mice; R. J. Lechleider for help with genotyping the
Madh5 mice; and A. Bernstein and C. Pawson for their help and
support during the early phases of this work.
References
1. Hara H, Ogawa M. Erythropoietic precursors in
mice with phenylhydrazine-induced anemia.Am J
Hematol. 1976;1:453-458.
2. Broudy V, Lin N, Priestley G, Nocka K, Wolf N.
Interaction of stem cell factor and its receptor c-kit
mediates lodgement and acute expansion of he-
matopoietic cells in the murine spleen. Blood.
1996;88:75-81.
3. Obinata M, Yania N. Cellular and molecular regu-
lation of erythropoietic inductive microenviron-
ment (EIM). Cell Struct Funct. 1999;24:171-179.
4. Palis J, Segel G. Developmental biology of eryth-
ropoiesis. Blood Rev. 1998;12:106-114.
5. Ohneda O, Yanai N, Obinata M. Microenviron-
ment created by stromal cells is essential for
a rapid expansion of erythroid cells in the
mouse fetal liver. Development. 1990;110:379-
384.
6. Mixter R, Hunt H.Anemia in the ﬂexed tailed
mouse, Mus musculus. Genetics. 1933;18:367-
387.
7. Gruneberg H. The anaemia of the ﬂexed-tail
mouse (Mus musculus L.), I: static and dynamic
haematology. J Genetics. 1942;43:45-68.
Figure 7. Identiﬁcation of the subpopulation of progenitor cells from untreated spleen that responds to BMP4. (A) Unfractionated, Lin and Lin cells from untreated
wild-type spleen were plated in 3 U/mL Epo without (f) or with 15 ng/mL BMP4 (u) and the induction of stress BFU-Es was analyzed. (B) KitLin and KitLin cells from
untreated wild-type spleen were plated in 3 U/mLEpo without (f) or with 15 ng/mLBMP4 (u) and the induction of stress BFU-Es was analyzed. (C) MEPs (LinSca1-IL-7R
KitCD34-FcRlow) isolated from bone marrow and spleen of wild-type mice were plated in 3 U/mL Epo without (f) or with 15 ng/mL BMP4 (u) and the induction of stress
BFU-Es was analyzed. N.D. indicates none detected. Error bars represent SEM.
BMP4 REGULATES STRESS ERYTHROPOIESIS 2747 BLOOD, 1APRIL 2005 VOLUME 105, NUMBER 7
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From 8. Gruneberg H. The anaemia of the ﬂexed-tail mice
(Mus musculus L.), II: siderocytes. J Genetics.
1942;44:246-271.
9. BatemanA, Cole R. Colony forming cells in the
livers of prenatal ﬂexed (f/f) anaemic mice. Cell
Tissue Kinet. 1972;5:165-173.
10. Cole R, Regan T. Haematopoietic progenitor cells
in the prenatal congenitally anaemic “Flexed-tail”
(f/f) mice. Br J Haematol. 1976;33:387-394.
11. Chui D, Sweeney G, Patterson M, Russell E. He-
moglobin synthesis in siderocytes of ﬂexed-tail
mutant (f/f) fetal mice. Blood. 1977;50:165-177.
12. Gregory C, McCulloch E, Till J. The cellular basis
for the defect in haematopoiesis in ﬂexed-tail
mice, III: restriction of the defect to erythropoietic
progenitors capable of transient colony formation
in vivo. Br J Haematol. 1975;30:401-410.
13. Coleman D, Russell E, Levin E. Enzymatic stud-
ies of the hemopoietic defect in ﬂexed mice. Ge-
netics. 1969;61:631-642.
14. Cole R, Regan T, Tarbutt R. Haemoglobin synthe-
sis in reticulocytes of prenatal f/f anaemic mice.
Br J Haematol. 1972;23:443-452.
15. Fleming M, Campagna D, Haslett J, Trenor C,
Andrews N.Amutation in a mitochondrial trans-
membrane protein is responsible for the pleiotro-
pic hematological and skeletal phenotype of
ﬂexed-tail (f/f) mice. Genes Dev. 2001;15:652-
657.
16. Massague J. How cells read TGF- signals. Nat
Rev Mol Cell Biol. 2000;1:169-178.
17. Massague J, Chen YG. Controlling TGF- signal-
ing. Genes Dev. 2000;14:505-520.
18. Huber T, Zhou Y, Mead P, Zon L. Cooperative ef-
fects of growth factors involved in the induction of
hematopoietic mesoderm. Blood. 1998;92:4128-
4137.
19. Akashi K, Traver D, Miyamoto T, Weissman I.A
clonogenic common myeloid progenitor that gives
rise to all myeloid lineages. Nature. 2000;404:
193-197.
20. Yang X, Castilla L, Xu X, et al.Angiogenesis de-
fects and mesenchymal apoptosis in mice lacking
SMAD5. Development. 1999;126:1571-1580.
21. Finkelstein L, Ney P, Liu Q, Paulson R, Correll P.
Sf-Stk kinase activity and the Grb2 binding site
are required for Epo-independent growth of pri-
mary erythroblasts infected with Friend virus. On-
cogene. 2002;21:3562-3570.
22. Marshall C, Kinnon C, ThrasherA. Polarized ex-
pression of bone morphogenetic protein-4 in the
human aorta-gonad-mesonephros region. Blood.
2000;96:1591-1593.
23. Melkun E, Pilione M, Paulson R.Anaturally oc-
curring point substitution in Cdc25A, and not Fv2/
Stk, is associated with altered cell cycle status of
early erythroid progenitor cells. Blood. 2002;100:
3804-3811.
24. Binnerts ME, Wen X, Cante-Barrett K, et al. Hu-
man crossveinless-2 is a novel inhibitor of bone
morphogenetic proteins. Biochem Biophys Res
Commun. 2004;315:272-280.
25. Peschle C, MigliaccioA, Migliaccio G, et al. Iden-
tiﬁcation and characterization of three classes of
erythroid progenitors in human fetal liver. Blood.
1981;58:565-574.
26. Lyon M, Rastan S, Brown S. Genetic Variants and
Strains of the Laboratory Mouse. 3rd ed. Oxford:
Oxford University Press; 1996:241.
27. Hunt H, Premar D. Flexed-tail a mutation in the
house mouse.Anat Rec. 1928;41:117.
28. Bult CJ, Blake JA, Richardson JE, et al. The
Mouse Genome Database (MGD): integrating
biology with the genome. NucleicAcids Res.
2004;32. Database issue:D476–D481.
29. Nakayama N, Lee J, Chiu L. Vascular endothelial
growth factor synergistically enhances bone mor-
phogenetic protein-4 dependent lymphohemato-
poietic cell generation from embryonic stem cells
in vitro. Blood. 2000;95:2275-2284.
30. Flanders K, Kim E, RobertsA. Immunohisto-
chemical expression of Smads 1-6 in the 15-day
gestation mouse embryo: signaling by BMPs and
TGF-betas. Dev Dyn. 2001;220:141-154.
31. Hogan B. Bone morphogenetic proteins: multi-
functional regulators of vertebrate development.
Genes Dev. 1996;10:1580-1594.
32. Ebert B, Bunn H. Regulation of the erythropoietin
gene. Blood. 1999;94:1864-1877.
33. Yanai N, Satoh T, Obinata M. Endothelial cells
create a hematopoietic inductive microenviron-
ment preferential to erythropoiesis in the mouse
spleen. Cell Struct Funct. 1991;16:87-93.
34. McNiece I, Langley K, Zsebo K. Recombinant
human stem cell factor synergises with GM-CSF,
G-CSF, IL-3 and Epo to stimulate human progeni-
tor cells of the myeloid and erythroid lineages.
Exp Hematol. 1991;19:226-231.
35. Harrison D, Russell E. The response of W/Wv and
Sl/Sld amaemic mice to hematopoietic stimuli.
Br J Haematol. 1972;22:155-167.
36. Murtaugh L, Chyung J, LassarA. Sonic hedge-
hog promotes somitic chondrogenesis by altering
the cellular response to BMP signaling. Genes
Dev. 1999;13:225-237.
37. Gregory C, McCulloch E, Till J. Transient erythro-
poietic spleen colonies: effects of erythropoietin
in normal and genetically anemic W/Wv mice.
J Cell Physiol. 1975;86:1-8.
38. BauerA, Tronche F, Wessely O, et al. The glu-
cocorticoid receptor is required for stress erythro-
poiesis. Genes Dev. 1999;13:2996-3002.
39. VannucchiA, Paoletti F, Linari S, et al. Identiﬁca-
tion and characterization of a bipotent (erythroid
and megakaryocytic) cell precursor from the
spleen of phenylhydrazine-treated mice. Blood.
2000;95:2559-2568.
40. Kina T, Ikuta K, Takayama E, et al. The monoclo-
nal antibody TER-119 recognizes a molecule as-
sociated with glycophorinAand speciﬁcally
marks the late stages of murine erythroid lineage.
Br J Haematol. 2000;109:280-288.
41. Kamenoff R. Effects of the ﬂexed-tail gene on the
development of the house mouse. J Morphol.
1935;58:117-155.
42. Christiansen J, Coles E, Wilkinson D. Molecular
control of neural crest formation, migration and
differentiation. Curr Opin Cell Biol. 2000;12:719-
724.
43. Sela-Donenfeld D, Kalcheim C. Regulation of the
onset of neural crest migration by coordinated
activity of BMP4 and Noggin in the dorsal tube.
Development. 1999;126:4749-4762.
2748 LENOX et al BLOOD, 1APRIL 2005 VOLUME 105, NUMBER 7
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From 